These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 3818014)

  • 21. The role of vasopressin in hypertension.
    Share L; Crofton JT
    Fed Proc; 1984 Jan; 43(1):103-6. PubMed ID: 6690329
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 19-Nordeoxycorticosterone excretion in male and female inbred salt-sensitive (S/JR) and salt-resistant (R/JR) Dahl rats.
    Gomez-Sanchez EP; Gomez-Sanchez CE
    Endocrinology; 1988 Mar; 122(3):1110-3. PubMed ID: 3342746
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Area postrema ablation and vascular reactivity in deoxycorticosterone-salt-treated rats.
    Bruner CA; Mangiapane ML; Fink GD; Webb RC
    Hypertension; 1988 Jun; 11(6 Pt 2):668-73. PubMed ID: 3391678
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vasopressin in the rat with partial nephrectomy-salt hypertension.
    Lee-Kwon WJ; Share L; Crofton JT; Shade RE; Brooks B; Muirhead EE; Manning M; Sawyer WH
    Clin Exp Hypertens (1978); 1981; 3(2):281-97. PubMed ID: 7215069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vasopressin V1a and V2 receptor mRNA in deoxycorticosterone acetate-salt hypertension in the rat.
    Risvanis J; Johnston CI; Phillips PA; Burrell LM
    Clin Sci (Lond); 1998 May; 94(5):517-23. PubMed ID: 9682675
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship of the antihypertensive effect of vasopressin withdrawal to sodium excretion in the Doca-salt hypertensive rat.
    Wang H; Wilson N; McNeill JR
    Clin Invest Med; 1993 Oct; 16(5):348-57. PubMed ID: 8261688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hormone and electrolyte changes in post-deoxycorticosterone salt hypertension in rats.
    Morton JJ; Kenyon CJ; Beattie EC
    J Hypertens; 1990 Nov; 8(11):1021-6. PubMed ID: 1963184
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blood pressure-lowering effect of an orally active vasopressin V1 receptor antagonist in mineralocorticoid hypertension in the rat.
    Burrell LM; Phillips PA; Stephenson JM; Risvanis J; Rolls KA; Johnston CI
    Hypertension; 1994 Jun; 23(6 Pt 1):737-43. PubMed ID: 8206571
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gonadal hormones modulate deoxycorticosterone-salt hypertension in male and female rats.
    Crofton JT; Share L
    Hypertension; 1997 Jan; 29(1 Pt 2):494-9. PubMed ID: 9039148
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between vasopressin and the anteroventral third ventricle region in deoxycorticosterone/salt hypertension (Brattleboro rat model).
    Berecek KH; Barron KW; Webb RL; Brody MJ
    Ann N Y Acad Sci; 1982; 394():392-7. PubMed ID: 6960771
    [No Abstract]   [Full Text] [Related]  

  • 31. Exchangeable sodium in DOC-salt and post-DOC-salt hypertension in rats.
    McAreavey D; Brown WB; Murray GD; Robertson JI
    J Hypertens; 1985 Jun; 3(3):275-9. PubMed ID: 3894516
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The importance of vasopressin in the mechanism maintaining hypertension in the rat.
    Yazaki Y; Ohuchi Y; Ashida T; Saito T
    Jpn Circ J; 1981 Sep; 45(9):1116-20. PubMed ID: 7300021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bradykinin B2-receptor blockade facilitates deoxycorticosterone-salt hypertension.
    Madeddu P; Parpaglia PP; Demontis MP; Varoni MV; Fattaccio MC; Tonolo G; Troffa C; Glorioso N
    Hypertension; 1993 Jun; 21(6 Pt 2):980-4. PubMed ID: 8389326
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antihypertensive effect of 19-acetylenic-deoxycorticosterone in inbred salt-sensitive rats.
    Azar ST; Melby JC; Griffing GT; Johnston JO
    Am J Hypertens; 1992 Jun; 5(6 Pt 1):372-7. PubMed ID: 1524762
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of vasopressin, the renin-angiotensin system and sex in Dahl salt-sensitive hypertension.
    Crofton JT; Ota M; Share L
    J Hypertens; 1993 Oct; 11(10):1031-8. PubMed ID: 8258666
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of nitrendipine on blood pressure, plasma renin, and exchangeable sodium in DOC-salt hypertension in the rat.
    Otipka NA; Tonolo G; Brown WB; Robertson JI
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S140-2. PubMed ID: 2455117
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exchangeable sodium measured serially in DOC-salt, post-DOC-salt, and Goldblatt hypertension in the rat.
    McAreavey D; Brown WB; Robertson JI
    J Cardiovasc Pharmacol; 1984; 6 Suppl 1():S126-33. PubMed ID: 6204131
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pressor response to vasopressin and impaired baroreflex function in DOC-salt hypertension.
    Matsuguchi H; Schmid PG
    Am J Physiol; 1982 Jan; 242(1):H44-9. PubMed ID: 7058912
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contribution of vasopressin to hypertension.
    Share L; Crofton JT
    Hypertension; 1982; 4(5 Pt 2):III85-92. PubMed ID: 7049934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic V2 vasopressin receptor stimulation increases basal blood pressure and exacerbates deoxycorticosterone acetate-salt hypertension.
    Fernandes S; Bruneval P; Hagege A; Heudes D; Ghostine S; Bouby N
    Endocrinology; 2002 Jul; 143(7):2759-66. PubMed ID: 12072411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.